These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27756767)

  • 1. Ranolazine reduces atrial fibrillatory wave frequency.
    Black-Maier EW; Pokorney SD; Barnett AS; Liu P; Shrader P; Ng J; Goldberger JJ; Zareba W; Daubert JP; Grant AO; Piccini JP
    Europace; 2017 Jul; 19(7):1096-1100. PubMed ID: 27756767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation.
    Carstensen H; Hesselkilde EZ; Haugaard MM; Flethøj M; Carlson J; Pehrson S; Jespersen T; Platonov PG; Buhl R
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):596-606. PubMed ID: 30661267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine in Cardiac Arrhythmia.
    Saad M; Mahmoud A; Elgendy IY; Richard Conti C
    Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms by Which Ranolazine Terminates Paroxysmal but Not Persistent Atrial Fibrillation.
    Ramirez RJ; Takemoto Y; Martins RP; Filgueiras-Rama D; Ennis SR; Mironov S; Bhushal S; Deo M; Rajamani S; Berenfeld O; Belardinelli L; Jalife J; Pandit SV
    Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e005557. PubMed ID: 31594392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation.
    White CM; Nguyen E
    Ann Pharmacother; 2017 Mar; 51(3):245-252. PubMed ID: 27758968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface ECG f Wave Analysis of Dofetilide Drug Effect in the Atrium.
    Raygor VP; Ng J; Goldberger JJ
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):644-8. PubMed ID: 25711372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation.
    Verrier RL; Kumar K; Nieminen T; Belardinelli L
    Europace; 2013 Mar; 15(3):317-24. PubMed ID: 23220484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiarrhythmic effects of ranolazine.
    Foster NJ; Haines DE
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S38-45. PubMed ID: 19898287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
    Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
    Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation.
    Zeemering S; Lankveld TAR; Bonizzi P; Limantoro I; Bekkers SCAM; Crijns HJGM; Schotten U
    Europace; 2018 Jul; 20(7):e96-e104. PubMed ID: 29016756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.
    Reiffel JA; Camm AJ; Belardinelli L; Zeng D; Karwatowska-Prokopczuk E; Olmsted A; Zareba W; Rosero S; Kowey P;
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1048-56. PubMed ID: 26226999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of I
    Nunoi Y; Kambayashi R; Goto A; Hagiwara-Nagasawa M; Chiba K; Izumi-Nakaseko H; Kawai S; Takei Y; Matsumoto A; Watanabe Y; Sugiyama A
    Heart Vessels; 2021 Jul; 36(7):1088-1097. PubMed ID: 33763729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine terminates atrial flutter and fibrillation in a canine model.
    Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
    Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface ECG f Wave Analysis at Initial Onset of Paroxysmal and Persistent Atrial Fibrillation.
    Sharma P; Barrett TW; Ng J; Knoten C; Ferreira AJ; Goldberger JJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):498-503. PubMed ID: 28190278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients.
    Simopoulos V; Hevas A; Hatziefthimiou A; Dipla K; Skoularigis I; Tsilimingas N; Aidonidis I
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):559-565. PubMed ID: 30255400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
    Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
    Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic properties of ranolazine: A review of the current evidence.
    Gupta T; Khera S; Kolte D; Aronow WS; Iwai S
    Int J Cardiol; 2015; 187():66-74. PubMed ID: 25828315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
    Aguilar M; Nattel S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.